Full-Time

Sr. Quality Assurance Specialist

Posted on 4/13/2025

Pfizer

Pfizer

10,001+ employees

Develops and manufactures biopharmaceutical products

Compensation Overview

$80.3k - $133.9k/yr

+ Bonus

Senior

No H1B Sponsorship

Sanford, NC, USA

No relocation support available. Work Location Assignment: On Premise.

Category
QA & Testing
Quality Assurance
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
Requirements
  • BA/BS degree in Biology, Chemistry, Micro and Bioanalytical with 2+ years of experience OR MBA/MS degree in Biology, Chemistry, Micro and Bioanalytical with any years of relevant experience OR Associate’s degree with 6+ years of experience OR High school diploma (or equivalent) with 8+ years of experience.
  • Experience in Quality Control Laboratory (e.g., transfer, equipment qualification, analytical testing, stability, etc.) cGMP’s Laboratory environment (Pharmaceutical industry)
  • Familiarized and experience in Pharmacopeia requirements (e.g., USP, JP, EMEA amongst others)
  • Experience or familiarized with Data Integrity requirements
  • Solid understanding of current Good Manufacturing Practices and relevant GxP regulations and standards
  • Strong critical thinking skills, problem solving and analytical skills
  • Attention to detail and ability to work independently
  • Ability to work effectively within own team and interdepartmental teams
  • Good working knowledge of Microsoft Excel and Word
  • Provide excellent communication writing and analytical skills
Responsibilities
  • Work to develop and implement quality assurance procedures and guidelines to support the Quality Control team’s testing and evaluation efforts.
  • Perform QA technical review for assigned areas such as Validation documents, Method transfer Protocol amongst others.
  • Provide final QA approval on more complex change control, effectiveness check, CAPA implementations, compendial assessments, and other documents associated with the business unit.
  • May also review and approve Deviation, complaints investigations, Laboratory investigations (OOS/OOT/OOE), and other Quality Events/Lab Events, Electronic build Master Batch, or any electronic record when needed, and all associated with compendial changes.
  • Drives compliance, efficiency, and process improvement projects.
  • Capable to make complex quality decisions in real time according to regulations and procedures.
  • Interfaces with internal partners to resolve technical issues.
  • Perform other duties as assigned and take ownership to support the implementation of activities needed for the start-up.
  • Evaluate and review clinical and commercial drug batches to ensure compliance with established specifications.
  • Approve investigations and change control activities to maintain compliance with configuration management policies.
  • Contribute to moderately complex projects, managing time effectively and developing short-term work plans.
  • Independently assess Change Control activities for potential Quality and Operational Good Manufacturing Practices (cGMP) impacts.
  • Ensure regulatory compliance with current Good Manufacturing Practices (GxP) and provide Quality Review and oversight of site documentation to meet global regulatory and Pfizer quality standards.
Desired Qualifications
  • Experience in quality administered systems
  • Strong organizational skills and attention to detail
  • Experience with regulatory compliance and documentation
  • Ability to mentor and review the work of other colleagues
  • Proven ability work in a team environment through conflict resolution and negotiation

Pfizer focuses on creating and producing healthcare products, particularly medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold globally. Pfizer's products include vaccines, cancer treatments, and other specialized medications. A notable achievement is its collaboration with BioNTech to develop a vaccine for COVID-19, which has played a significant role in addressing the pandemic. Unlike many competitors, Pfizer emphasizes its commitment to public health by providing vaccines to underserved communities and continuously expanding its product offerings through new approvals. The goal of Pfizer is to improve health outcomes worldwide by delivering effective healthcare solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Simplify Jobs

Simplify's Take

What believers are saying

  • Activist investor Starboard Value's $1B stake may drive strategic changes and increase value.
  • Pfizer's investment in Enara Bio strengthens its position in the immunotherapy market.
  • Backing Promise Bio aligns with Pfizer's strategy to enhance its precision medicine portfolio.

What critics are saying

  • Emerging biotech companies like Trimtech and Normunity could impact Pfizer's market share.
  • Slowdown in COVID-19 vaccine demand poses potential revenue challenges for Pfizer.
  • Activist investor involvement may pressure Pfizer to alter business strategies.

What makes Pfizer unique

  • Pfizer's partnership with BioNTech led to a highly effective COVID-19 vaccine.
  • Pfizer invests in AI disease models, enhancing R&D capabilities and drug discovery.
  • Pfizer's focus on precision medicine diversifies its therapeutic areas and strengthens its portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Relocation Assistance

Company News

Finsmes
Mar 5th, 2025
Trimtech Therapeutics Raises $31M in Seed Funding

Trimtech Therapeutics, a Cambridge, UK-based biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, raised $31M in Seed funding

Business Wire
Jan 16th, 2025
Normunity Closes $75 Million Series B Financing to Advance Lead Drug Program Into the Clinic and Broaden Pipeline of Novel Anti-Cancer Therapies Targeting Untapped Drug Mechanisms

Normunity, a biotechnology company creating novel anti-cancer therapies, today announced that it has closed a Series B financing for $75 million. The

TechCrunch
Oct 23rd, 2024
Promise Bio exits stealth backed by Pfizer and AstraZeneca | TechCrunch

The company has made it easier to test for different protein modifications which are critical to the treatment of autoimmune diseases.

The Wall Street Journal
Oct 7th, 2024
Exclusive | Activist Starboard Value Takes $1 Billion Stake in Pfizer

The drugmaker’s shares have slumped as demand for Covid-19 vaccines and treatments had slowed.

Benzinga
Oct 3rd, 2024
Enara Bio raises $32.5 million Series B financing to advance first-in-class pipeline of TCR-based immunotherapies targeting novel Dark Antigens®

New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara BioCapital and SV Health InvestorsEnara Bio's EDAPT® platform is

INACTIVE